Neogenomics (NEO) Payables (2010 - 2026)

Neogenomics (NEO) has reported Payables for 17 consecutive years, with $25.9 million the latest figure, recorded in Q1 2026.

• Payables for Q1 2026 came in at $25.9 million, down 88.08% year-over-year; the trailing twelve-month figure through Mar 2026 was $25.9 million (down 88.08% YoY), and the FY2025 annual result was $23.1 million, down 89.62% from the prior year.
• Payables was $25.9 million for Q1 2026 at Neogenomics, up from $23.1 million in the prior quarter.
• Over five years, Payables peaked at $222.4 million in Q4 2024 and troughed at $13.7 million in Q3 2022.
• Average Payables over 5 years is $67.1 million, with a median of $22.6 million recorded in 2025.
• Year-over-year, Payables jumped 1189.84% in 2024 and slumped 89.62% in 2025.
• Over 5 years, Payables stood at $20.5 million in 2022, then declined by 0.86% to $20.3 million in 2023, then jumped by 993.66% to $222.4 million in 2024, then plunged by 89.62% to $23.1 million in 2025, then gained by 12.16% to $25.9 million in 2026.
• Per Business Quant data, the three most recent Payables figures were $25.9 million in Q1 2026, $23.1 million in Q4 2025, and $22.6 million in Q3 2025.